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There is evidence that frontal-subcortical circuits play an important role in the initial 
presentation of dementia in Down syndrome (DS), including changes in behaviour, a 
decline in working memory and executive dysfunction. We evaluated 92 individuals 
with DS (≥ 30 years of age), divided into three groups by diagnosis—stable cognition, 
prodromal dementia and Alzheimer’s disease (AD). Each individual was evaluated 
with an executive protocol developed for people with intellectual disabilities and was 
rated for behaviours related to frontal lobe dysfunction (disinhibition, executive 
dysfunction and apathy) by an informant using the Frontal Systems Behavior Scale 
(FrSBe). Informant-reported behaviours related to fr ntal lobe dysfunction were 
found to correlate negatively with executive function performance. Disinhibition and 
executive dysfunction were associated with the clinical stage of dementia. The odds 
of having AD increased in parallel with increases in the domain and total FrSBe 
scores (p ≤ 0.5). Disinhibition, executive dysfunction and apathy should be taken into 
consideration during the clinical evaluation of adults with DS, and future studies 






















Down syndrome (DS) is associated with premature development of the 
neuropathology typical of Alzheimer’s disease (AD), including early amyloid burden 
(senile plaques) and neurotoxic neurofibrillary tangles (Holland and Oliver, 1995; 
Wisniewski et al., 1985; Zigman, 2013). Although a deficit in episodic memory 
appears to be the main early characteristic of AD in the general population, 
behavioural symptoms typically appear later in the course of dementia (Gregory and 
Hodges, 1996; Sperling et al., 2010). In adults with DS and AD, the symptomatology 
at the onset of dementia has been described as atypical (Adams and Oliver, 2010; Ball 
et al., 2006; Deb et al., 2001; Nelson et al., 2001). It is not clear however if this is due 
to the “camouflage” provided by pre-existing cognitive deficit or if it is due to 
abnormalities related to the DS-specific brain phenotype (Holland et al., 1998). 
Studies suggest that, in individuals with DS, typical symptoms of frontal lobe 
dysfunction, such as behavioural changes (disinhibition, executive dysfunction and 
apathy) appear as an early manifestation prior to the appearance of short-term 
memory impairment, which is the characteristic early feature of AD (Ball et al., 2006; 
Deb et al., 2001; Dekker et al., 2018; Fonseca et al., 2016; Oliver et al., 2011).  
The frontal lobe is responsible for the interconnections between the major 
sensory and motor systems of the brain, integrating the components necessary for 
human behaviour (Goldberg and Bougakov, 2005). Neuropsychological aspects 
related to the frontal lobe include executive functions (such as planning, inhibitory 
control, working memory and abstract thinking), atten ion and behaviour. In a recent 
study, our group found that behaviours related to frontal lobe dysfunction are already 
present (i.e. before age-related cognitive decline or the development of AD) during 













behaviours can have an impact on the initial presentatio  of AD in DS population 
(Fonseca et al., unpublished results). There is evidence that neuropsychological 
performance related to prefrontal lobe function is most often affected in adults with 
DS and AD, resulting in declines in executive function (Adams and Oliver, 2010; Ball 
et al., 2008) and working memory (Ghezzo et al., 2014; Nelson et al., 2001; Oliver et 
al., 1998). Also, a recent study involving a large sample of adults with DS found that 
those with prodromal dementia performed significantly worse than those with 
preclinical dementia on cognitive outcomes related o executive function and 
attention, along with those pertaining memory domains (Firth et al., 2018; Startin et 
al., 2018). Given the few studies involving pre-clinical symptoms in people with DS, 
researchers emphasize the importance of developing cr teria for defining prodromal 
dementia, early dementia, and their distinction in adults with intellectual disabilities 
(Krinsky-McHale and Silverman, 2013; Silverman et al., 2013). 
In individuals with DS, behaviours related to frontal lobe dysfunction can be 
present throughout life, because of the pre-existing frontal lobe hypoplasia and poor 
development of regions with projections to and from neurons of the prefrontal cortex 
(Powell et al., 2014; Raz et al., 1995; Wang et al., 1992). In such individuals, positron 
emission tomography with Pittsburgh compound B (Klunk et al., 2004) indicated 
brain deposition of β-amyloid to occur first in the striatum, followed by the pre-
frontal and anterior cingulate cortices, and it subsequently spreads to other regions of 
the brain (Annus et al., 2016). That early striatal p ttern of cerebral amyloidosis is 
like what is seen in the autosomal dominant familial forms of AD (Cohen et al., 2018; 
Shinohara et al., 2014), which has led some research rs to hypothesise that it is 
related to early overproduction and/or abnormal clearance of amyloid (Annus et al., 













striatum appear very late in the course of the disease (Braak and Braak, 1990; Cohen 
et al., 2018). Apart from the early striatal depositi n and the consequent hypothesised 
effect on fronto-striatal pathways, in general the distribution of brain amyloid 
deposition in individuals with DS appears to be consistent with that observed in 
individuals with sporadic or familial AD (Bateman et al., 2012; Klunk et al., 2004). 
Recent evidence suggests that amyloid accumulation may be a potential biomarker for 
cognitive decline in adults with DS in the prodromal phase of AD (Hartley et al., 
2017). It is known that frontal circuits connect the regions of the frontal cortex to the 
striatum, globus pallidus, substantia nigra and thalamus (Mega and Cummings, 1994). 
One recent study suggested that the myelination process in the frontal pathways is 
particularly vulnerable to ageing in individuals with DS (Powell et al., 2014), and the 
breakdown of late-stage myelin might be related to the subsequent amyloid deposition 
associated with AD (Bartzokis, 2011, 2004). 
Three major frontal-subcortical circuits have been associated with major 
neuropsychiatric manifestations (Cummings, 1995). The first originates in the 
dorsolateral prefrontal cortex and is related to executive dysfunction. The second is 
the orbitofrontal cortex circuit, which is linked to disinhibition and obsessive-
compulsive symptoms. Cognitive impairment associated with the orbitofrontal circuit 
may be observed in tasks involving emotional decision-making and behavioural 
inhibition (Bechara et al.,1994). The last is the anterior cingulate circuit and is 
associated with a lack of motivation or apathy, error correction and response 
inhibition (Tekin and Cummings, 2002). Disruption at any point in any of the three 
frontal-subcortical circuits (including striatal regions, basal ganglia, and thalamus) 














The Frontal Systems Behavior Scale (FrSBe), devised by Grace and Malloy 
(2001), is a questionnaire designed specifically to evaluate behaviours related to 
frontal lobe dysfunction (namely executive dysfunction, disinhibition and apathy) that 
compares the current and past behaviour of an individual. The FrSBe has been used in 
studies of various types of dementia, including AD (Malloy et al., 2007; Peavy et al., 
2013; Ready et al., 2003; Stout et al., 2003). Higher FrSBe scores translate to less 
adapted behaviour. In a study investigating the neuropsychiatric features of frontal 
lobe dysfunction in autopsy-confirmed AD, frontally mediated behaviours, as 
assessed by the FrSBe, were found to have been affected arly in the progression to 
AD. However, only a few studies have investigated the relationship between the 
expression of frontally mediated behaviours and dementia in DS (Adams and Oliver, 
2010; Ball et al., 2010, 2008). To our knowledge, this is the first study to use a 
specific behaviour rating scale for the assessment of disturbances associated with 
frontal-subcortical brain circuits in individuals with DS. The objectives of this study 
were to examine the relationship between frontally mediated behaviours and 
executive functions and to determine whether the FrSBe score indicates the clinical 
diagnosis of prodromal dementia and AD in individuals with DS. 
 
2. Methods 
2.1. Study sample 
In the study we included 92 individuals with DS, all of whom were ≥ 30 years of 
age (mean: 42.4 years; standard deviation: 8.4 years; r nge 30–64 years). Of the 92 
individuals evaluated, 58 (63%) were males. All individuals met the criteria for a 
diagnosis of DS, as established in the International Cl ssification of Diseases, 10th 













or previously enrolled in programs for adults with intellectual disability offered by the 
Association of Parents and Friends of Individuals with Intellectual Disability of Sao 
Paulo or the Association for the Holistic Development of Individuals with Down 
Syndrome, as well as from among individuals who became aware of the study and 
demonstrated an interest in participating. The study was approved by the Research 
Ethics Committee of the University of São Paulo School of Medicine Hospital das 
Clínicas and was registered with the National Committee for Ethics in Research 
through the Plataforma Brasil (CAAE no. 37381414.8.0000.0065). For all of the 
individuals included, the objectives of the study were explained in a simple, concrete 
manner, and any questions or concerns they had were addressed. Written informed 
consent was obtained not only from the individuals with DS but also from their legal 
guardians. Assessments were performed in sound-proof rooms arranged for the 
evaluation, either at the Institute of Psychiatry of the University of São Paulo School 
of Medicine Hospital das Clínicas or at one of the Associations involved.  
 
2.2. Clinical assessment and diagnosis 
All individuals with DS underwent dementia assessment with the Cambridge 
Examination for Mental Disorders of Older People with Down Syndrome and Others 
with Intellectual Disabilities (CAMDEX-DS) informant questionnaire (Ball et al., 
2004), an instrument adapted for use specifically in adults with DS that considers 
deterioration from the best level of functioning and has been validated for use in 
Brazil (Fonseca et al., in press). Data supplement 1 describes all the informant-based 
measures used. All of the informants were closely rated to the participant, with 
whom they had been in daily contact for at least ten years. The informant 













with knowledge of the specificities of DS. As part of the CAMDEX-DS 
questionnaire, information on current use of medications, living arrangements, 
relationship with informants, duration of contact, education and employment were 
investigated. For subsequent analysis the medication variable was dichotomised and 
considered “yes” whenever participants were taking medication considered to affect 
the central nervous system, modulating the effects of neurotransmition (e.g. 
antipsychotic, antidepressant, mood stabilizer, acetylcholinesterase inhibitor, 
anticonvulsant, antiparkisonian agent, and stimulants) with no determination 
concerning effects of any single medication. Besides these variables, the clinical 
anamnesis also included the investigation on family history of AD and sedentary life 
according to the informant report. 
The clinical evaluation of dementia was based on the criteria established in the 
CAMDEX-DS, the ICD-10 (World Health Organization,  2004) and the Diagnostic 
and Statistical Manual of Mental Disorders, fifth edition (American Psychiatric 
Association, 2013) and was performed by an evaluator wh  was blinded to the results 
of the neuropsychological assessment and to those of the other instruments. The 
individuals were divided into three diagnostic categories: stable cognition, prodromal 
dementia and AD. Prodromal dementia was defined as an intermediate group of 
probable early dementia in which the cognitive or functional decline was superior to 
that expected for non-pathological ageing but not severe enough to meet the criteria 
for a diagnosis of dementia. 
 
2.3. Behaviours related to frontal lobe dysfunction 
For measures of neuropsychiatric manifestations related to the frontal-subcortical 













2003), which provides scores for executive dysfunctio , disinhibition and apathy 
domains, from which a total score is derived. The scale compares the past and current 
behaviours of the individual. For the present analysis we considered only the current 
behaviour scores. The FrSBe was applied by a psychiatrist trained in the use of the 
instrument, with knowledge of the specificities of DS and blinded to the clinical 
evaluations performed with the CAMDEX-DS. The FrSBe has been validated for use 
in different types of dementia, having been shown to discriminate well between AD 
and frontotemporal dementia (FTD) and to be useful in assessing the three frontal 
syndromes, in isolation or in combination (Malloy et al., 2007; Stout et al., 2003). To 
our knowledge, the FrSBe has never before been used in the assessment of behaviours 
related to frontal lobe dysfunction in individuals with DS.  
 
2.4. Level of intellectual disability 
Premorbid severity of intellectual disability was defined by a psychiatrist through 
analysis of the maximum level of individual adaptive behaviour achieved throughout 
life using a background information anamnesis according to the American 
Association on Intellectual and Developmental Disabilities framework (AAIDD, 
2010) and the results of a neuropsychological assessm nt of intellectual functioning 
using the Wechsler Abbreviated Scale of Intelligence (WASI [Wechsler, 1999]) that 
had been performed before there was any sign of cognitive decline. The psychiatrist 
was blinded to the CAMDEX-DS results and other neuropsychological evaluations. 
The level of intellectual disability was categorised by ICD-10 code: F70 (mild 
intellectual disability); F71 (moderate intellectual disability); F72 (severe intellectual 
disability); F73 (profound intellectual disability); and F79 (unspecified intellectual 













because of the presence of cognitive decline and a lack of information regarding the 
history of the individual.  
 
2.5. Neuropsychological assessment 
A neuropsychologist with experience in DS and intellectual disability performed 
the neuropsychological assessment, which consisted in the administration of the 
Cambridge Cognitive Examination for Older Adults with Down Syndrome 
(CAMCOG-DS), as described by Ball et al. (2004); the Wechsler Abbreviated Scale 
of Intelligence (WASI [Wechsler, 1999]); and a executive protocol devised by Ball et 
al. (2008).  
The CAMCOG-DS is the neuropsychological section of the CAMDEX-DS and 
contains subscales for the following domains: orientation; language (comprehension 
and expression); memory (new learning, remote and recent); attention; praxis 
(drawing of complex figures and ability to carry out complex tasks); abstract thinking; 
and perception. As in a previous study of individuals with DS and AD (Ball et al., 
2006), the CAMCOG-DS performance specifically relatd to frontal lobe function 
was analysed as a composite domain, designated “EF and attention”, which combines 
the scores for verbal fluency, attention-calculation, clock drawing and abstract 
thinking. 
The WASI, adapted and validated for use in Brazil (Trentini et al, 2014), was 
applied in its reduced version, with the Vocabulary nd Block Design subtests, 
providing an estimated intelligence quotient, which facilitated the definition of 
intellectual disability for individuals who showed no signs of cognitive decline. For 
cases of dementia or suspected cognitive decline, w considered cognitive 













For the neuropsychological evaluation of executive functions, we used a protocol 
designed specifically for individuals with DS, developed by researchers at the 
University of Cambridge (Ball et al., 2008) and used in previous studies in the area 
(Adams and Oliver, 2010; Annus et al., 2016; Ball et al., 2008). In addition to six 
tasks related to executive function (CAMCOG-DS fluency item, Cats and dogs- a task 
based on day-night stroop (Gerstadt et al., 1994), Spatial reversal- based on procedure 
used by McEvoy et al. (1993), Weigl sorting (Grant and Berg 1948), Tower of 
London (Shallice, 1982), Scrambled boxes (Griffith et al., 1999)), the protocol 
includes two tasks related to executive memory (Prospective memory- the 
“remembering to belong” subtest of the Rivermead Behavioural Memory Test for 
Children (Wilson et al., 1991), and Object memory from the battery of 
neuropsychological tests employed by Oliver et al. (1998) in the identification of 
cognitive impairment. Test content, modifications ad administration are described in 
Ball et al. (2008). Data supplement 1 shows all the neuropsychological measures 
applied and cognitive processes assessed.  
 
2.6. Statistical analysis 
For the sample as a whole and for each diagnostic group (stable cognition, 
prodromal dementia and AD), descriptive analyses of the demographic variables are 
presented as absolute and relative frequencies or ameans and standard deviations. 
Between-group differences were assessed with Kruskal-Wallis test for continuous 
variables and with Fisher’s exact test for categorical variables for which the number 
of cases was less than five for one or more variable; for all other categorical variables, 
between-group differences were assessed with Pearson’s chi-square test. Spearman’s 













score and the cognitive performance of the individual. Multiple linear regressions 
were conducted in order to determine whether the total FrSBe scores and the 
cognitive performance test results varied among the three different diagnostic groups. 
The total FrSBe scores and the cognitive performance scores were selected as the 
primary outcome of interest. To assess the strength of t e association of the diagnostic 
group with the total FrSBe score and with cognitive performance, all linear regression 
models were adjusted for age, gender, type of education, degree of intellectual 
disability, and current use of medications affecting the central nervous system. In 
addition, to determine the degree to which informant reports of behaviours related to 
frontal lobe dysfunction were predictive of the diagnosis, we created three 
dichotomous variables (AD versus prodromal dementia, AD versus stable cognition 
and prodromal dementia versus stable cognition). We performed multiple logistic 
regression analyses, assigning those dichotomous variables as the dependent variables 
(primary outcomes) and each of the total FrSBe scores as the independent (predictor) 
variables, including age, gender, degree of intellectual disability and current use of 
medications affecting the central nervous system as covariates. The level of statistical 
significance was set at 5%. All selected data were tabulated with the Research 
Electronic Data Capture program (Harris et al., 2009), and the analyses were carried 
out using the SPSS Statistics software package, version 24.0 (IBM Corporation, 
Armonk, NY, USA).  
 
3. Results 
3.1. Demographic and clinical data 
The demographic characteristics of the sample are shown in Table 1. Of the 92 













(18.5%) were classified as having prodromal dementia and 13 were classified as 
having AD (14.1%). During the evaluation period, 48 (52.2%) of the individuals had 
hypothyroidism and all those individuals were receiving effective treatment. Twenty 
(21.7%) of the 92 individuals were using medications that affect the central nervous 
system: eight were using an antipsychotic; nine were using an antidepressant; four 
were using a mood stabiliser; two were using an acetylcholinesterase inhibitor; one 
was using an anticonvulsant; and one was using an antiparkinsonian agent. Of those 
20 individuals, 14 were using one such medication and six were using two. 
There were significant differences among the diagnostic groups for the variables 
age, family history of AD, use of medication affecting the central nervous system, 
sedentary lifestyle, living arrangements, relation t  the informant and duration of 
contact with the informant. On average, those in the prodromal dementia and AD 
groups were older than were those in the stable cogniti n group. Individuals with AD 
tended to use more medications affecting the central ervous system. In addition, the 
individuals with AD were most likely to have a family history of AD and to have a 
sedentary lifestyle, whereas the individuals in the prodromal dementia group 
presented results for those two variables that were intermediate between the results 
obtained for the other two groups. In comparison with the individuals in the stable 
cognition and prodromal dementia groups, those in the AD group were more likely to 
live in a nursing home and less likely to live at home with relative, as well as being 
more likely to have a caregiver than a parent as their informant. For the relation to the 
informant, the prodromal dementia group presented a result intermediate between that 
of the AD group and that of the stable cognition group. The mean duration of contact 
between the informant and the individual with DS was longer in the AD group than in 













deviation for that variable and was therefore statitically similar to the two other 
groups, whereas the stable cognition and prodromal dementia groups differed 
significantly from each other.  
TABLE 1 HERE 
 
3.2. Relationship between behaviours related to frontal lobe dysfunction and 
diagnostic status 
Table 2 shows the associations between the informant reports of behaviours 
related to frontal lobe dysfunction and the various diagnoses, adjusted for age, gender, 
type of education, degree of intellectual disability and use of medications affecting the 
central nervous system. Executive dysfunction showed a clear association with the 
diagnostic group, even when adjusted for the other variables. In terms of the 
frequency of disinhibition, there was a clear distinction between the stable cognition 
and prodromal dementia groups, although the difference in relation to the AD group 
was linked to the adjustment variables. Without adjustment for age, gender, type of 
education, degree of intellectual disability and medication use, there were significant 
differences among the groups for all of the items (p < 0.05 for all).  
Within the stable cognition group, we identified four individuals with higher 
(outlier) FrSBe scores for apathy. As the total FrSBe score involves the sum of the 
FrSBe domain scores, we performed both analyses: with the whole sample and 
excluding those four individuals from our analysis of apathy and total FrSBe. As can 
be seen in Table 4, after excluding the outliers, we also found a difference for the total 
FrSBe score, although the difference for apathy continued to be modelled by all 
adjusted variables.  














3.3. Relationship between behaviours related to frontal lobe dysfunction and 
cognitive performance 
Six participants did not perform direct cognitive assessment. Three due to 
advanced stage of dementia, two due to inability in expressive language (no speech), 
and one because he refused to continue the cognitive assessment even though he 
maintained his consent for all other evaluations. Table 3 shows the correlation 
between the informant-reported scores for the FrSBe items and the performance of the 
individuals on the cognitive tasks (N=86). With the exception of one of the items 
analysed (correlation of disinhibition and verbal fluency), all cognitive tasks were 
shown to have some association with all three of the behaviours related to frontal lobe 
dysfunction investigated and with the total FrSBe score, either considering the 
executive protocol devised by Ball et al. (2008) or the CAMCOG-DS executive 
function and attention tasks. Cognitive performance correlated most strongly with the 
executive dysfunction domain, the total FrSBe score and the apathy domain, in that 
order. 
TABLE 3 HERE 
 
3.4. Relationship between executive performance and diagnostic status 
Analysis of the association between the diagnostic tatus and performance on 
cognitive tasks related to executive function showed that, when adjusted for age, 
gender, type of education, degree of intellectual disability and use of medication 
affecting the central nervous system, half of the tasks proposed in the study protocol 
had a significant association with the diagnosis (Table 4). The cognitive tasks that 













Sorting, Tower of London and Prospective Memory, as well as the combined score 
for all of the executive tests of the protocol. However, for the Weigl Sorting and 
Tower of London tasks, the association was strong only in relation to a diagnosis of 
prodromal dementia. On all four of those tasks, the individuals diagnosed with 
dementia scored very close to the minimum (floor effect).  When not adjusted for age, 
gender, type of education, intellectual disability and medication, all of the tasks had a 
p-value below 0.05, which shows that the adjustment variables had a strong influence 
on executive performance. For the executive functio and attention tasks of the 
CAMCOG-DS, those variables also influenced the cognitive performance, although it 
was not possible to establish a direct association with the diagnosis, despite the fact 
that the score diverged widely among the groups. Data supplement 2 shows the 
number of individuals with floor and ceiling scores on individual tasks for each of the 
diagnostic groups. 
TABLE 4 HERE 
 
3.5. Impact of behaviours related to frontal lobe dysfunction on the diagnostic status 
As can be seen in Table 5, the odds of being diagnosed with AD increased in 
parallel with increases in the specific total FrSBe score. The data in the table show by 
how much a one-point increase in that specific score increases the chance of each 
given diagnosis over the previous (less severe) one. When we compared the 
prodromal dementia and stable cognition groups, we found a greater number of FrSBe 
items for which higher scores increased the chance of that individual to be diagnosed 
with prodromal dementia, namely disinhibition, executive dysfunction and the total 
FrSBe score. The executive dysfunction and total FrSBe scores were found to be 













of a diagnosis of prodromal dementia. When we excluded the outlier values for the 
apathy and total FrSBe scores (for the four individuals in the stable cognition group), 
apathy was found to be a predictor of a diagnosis of pr dromal dementia over stable 
cognition (odds ratio = 1.087; p = 0.026). For all other analyses, exclusion of the 
outliers did not alter the results.  
TABLE 5 HERE 
 
4. Discussion 
In our sample of adults with Down syndrome, we found that behaviours related to 
frontal lobe dysfunction were predictive of a diagnosis of prodromal dementia or AD. 
Informant reports of such behaviours were found to correlate with the performance of 
the individual on cognitive tasks that involve executive functions. These findings 
support our hypothesis that behaviours related to frontal lobe dysfunction and 
cognitive dysfunction in the executive domain manifest during the progression to 
clinical AD in adults with DS. 
It is known that frontal-subcortical syndromes can reflect disruption of working 
memory and executive function (Cummings, 1995). In the present study, we found a 
correlation between the performance of individuals on executive tasks and informant 
reports of frontally mediated behaviours. As expected, he correlation was greater for 
the participants' performance with the executive domain of the informant's report. In 
addition, there was a significant difference between the total of the proposed 
executive tasks and the three clinical diagnoses, with those with AD being considered 
worse performing followed by those with prodromal diagnosis. In a comparison of 
sixteen months of follow-up, researchers found thatonly individuals considered in 
cognitive deterioration presented a decline in the m asures of executive functions 













cognitive tasks with the FrSBe domains for those tests involving working memory 
(e.g., Cats and dogs, Tower of London, Object memory), followed by the task 
involving prospective memory. Functional neuroimaging studies have correlated 
several regions of the frontal lobe (dorsolateral prefrontal cortex, right lateral 
prefrontal cortex, anterior cingulate gyrus, and medial frontal lobe) in the processes 
involved in working memory (Nissim et al., 2016; Burgess et al., 2001; Cabeza and 
Nyberg, 2000). Research also suggests that the frontal cortex would encode 
prospective action (Mackey and Curtis, 2017). Patients with frontal lobe lesions were 
particularly impaired in prospective memory tasks (Fortin et al., 2002; Cockburn, 
1995). Disinhibition was the domain with the lowest correlation with the cognitive 
tasks in our study, although the correlation still exists with the exception of one of the 
cognitive tasks (verbal fluency). Lesions in this region is known to not necessarily 
leave obvious cognitive deficits but have a great impact on the expression of 
behaviour (Goldberg and Bougakov, 2005). In studies involving patients with 
orbitofrontal lesions, they showed impairment in decision-making despite adequate 
performance in traditional executive function tests (Damasio, 1996; Bechara et al, 
1994). However, the evaluation of cognitive performance alone, at a single time point, 
is not sufficient to draw any conclusions regarding diagnosis. Although our study 
used cognitive tasks developed specifically for individuals with DS, the results of 
more than half of the tests used in our study were strongly influenced by age, gender, 
type of education, level of intellectual disability and use of medications affecting the 
central nervous system, thus precluding us from ident fying any direct associations 
between those results and the diagnostic groups. That underscores the importance of 
comparing individual performance at two different time points during cognitive 













strength of performance, even considering the previous level of intellectual disability; 
as well as the broad variability of individual cognitive performances, substantially 
influenced by emotional issues, empathy, mood and other subtle conditions, make it a 
challenge to perform a single assessment of the cognitive performance of an 
individual with intellectual disability. Making such an assessment as part of a 
neuropsychological evaluation requires specific knowledge and training in the area.  
Our findings regarding the relationship between cognitive performance and 
diagnosis differs from that of the original executive protocol study (Ball et al., 2008), 
in which the AD group showed impaired performance on all cognitive tasks, even 
when the results were adjusted for age and degree of intellectual disability. However, 
methodological differences between the two studies preclude direct comparisons. 
First, our study included a prodromal dementia group, whereas the original protocol 
study compared only individuals with and without AD. Second, in addition to age, 
gender and degree of intellectual disability, we adjusted for type of education and the 
use of medications affecting the central nervous system. Our study also considered 
not only individuals with mild and moderate intellectual disability but also those with 
severe intellectual disability.  
In view of our findings and defining prodromal dementia as an intermediate 
clinical state between stable cognition and AD, we can hypothesise that the symptoms 
of dementia related to frontal lobe function first appear in the prodromal phase, with 
an increase in disinhibition and executive dysfunction, whereas the features of apathy 
appear after AD has become established, all such symptoms being heightened by the 
progression of the disease. Another study employing the FrSBe showed that changes 
in behaviours related to frontal lobe dysfunction are common in the early phases of 













is any evidence of a decline in functional abilities (Ready et al., 2003). In a study 
using the FrSBe to discriminate between FTD and AD, increases in apathy and 
executive dysfunction were observed after the onset of both diseases, although only 
the individuals in the FTD group showed an increase in disinhibition (Malloy et al., 
2007), which differs from our findings. One possible explanation for that discrepancy 
might be related to the behavioural phenotype of DS throughout life, a hypothesis that 
would need to be further investigated.. In another study employing the FrSBe, apathy 
and executive dysfunction were found to be prominent in all phases of AD, whereas 
the level of disinhibition was found to be high only in severe AD (Stout et al., 2003). 
Studies investigating behavioural and psychological symptoms in different forms of 
dementia, including AD, have shown that apathy was present in all forms and 
correlated with executive function (Perri et al., 2014). Our findings regarding the 
onset of behaviours related to frontal lobe dysfunctio  and their impact during the 
progression of the disease agree with those of a recent collaborative study, conducted 
by the University of Cambridge and University of São Paulo, using the CAMDEX-
DS, which indicated an initial impact on executive dysfunction together with 
memory/orientation decline, with the appearance of disinhibited and apathetic signs 
throughout the dementia process (Fonseca et al., unpublished results). However, as 
our study had a cross-sectional design, this is a finding that could be verified only in a 
longitudinal follow-up study. If we compare the data obtained for our stable cognition 
group with those of the FrSBe normative sample (Grace nd Malloy, 2001), we can 
see that, even when there was no evidence of cognitive decline, the executive 
dysfunction domain and total FrSBe scores differed by more than 10 points, in the 
direction of disruptive behaviour, considering the m an and standard deviation for the 













Nevertheless, the differences in age and education from our sample in respect to the 
normative sample do not allow us to reach any conclusions, there being only a 
tendency toward behaviours related to frontal lobe dysfunction in the population with 
DS. 
In our study, a number of demographic characteristics were associated with the 
diagnostic group. Age was strongly associated with the clinical diagnosis. For the 
general population, age is considered the main risk factor for the development of late-
onset dementia (Vardarajan et al., 2014). For indivduals with DS, there is evidence 
that age is a major risk factor for degenerative processes (Cole et al., 2017; Head et 
al., 2011; LeVine et al., 2017), such individuals showing an age-dependent increase in 
the prevalence of dementia symptoms (Coppus et al., 2006; Holland et al., 2000), 
which occur nearly two decades earlier than in the general population. In our sample, 
the individuals in the stable cognition group were considerable younger than were 
those in the prodromal dementia group, who were in tur younger than those in the 
AD group, similar to what has been reported for mild cognitive impairment in the 
general population (Petersen et al., 2014). That clear difference in age probably also 
influenced other variables examined in our sample, such as the relation to and 
duration of contact with the informant. However, it is noteworthy that the minimum 
duration of contact with the informant was 10 years in all three groups. We can 
hypothesise that the older age of the individuals in the AD group increased the 
likelihood that they had lost their parents and would therefore have a professional 
caregiver as an informant. The living arrangements might also indicate the greater 
need for professional support among those diagnosed with AD, who more often lived 
in nursing homes and less often lived at home with their parents. Further 













lifestyle and a family history of AD were also associated with the diagnosis. 
Nevertheless, as this was a cross-sectional study, we cannot comment on the nature of 
these associations.  
Our study has some limitations that need to be considered. The first is the small 
sample size, especially in the prodromal dementia ad AD groups. Another limitation 
is the fact that we found no instrument designed specifically to evaluate frontally 
mediated behaviours in individuals with DS. Some of the questions presented by the 
FrSBe might not be appropriate for use in that population. In addition, the behaviours 
related to frontal lobe dysfunction were assessed on the basis of informant reports. In 
some studies, the FrSBe has also been applied directly to the subjects (Batistuzzo et 
al., 2009; Schiehser et al., 2013). Furthermore, our study had a cross-sectional design, 
whereas a longitudinal analysis would make it possible to understand the evolution of 
the such behaviours and analyse the nature of the associ tions.  
In conclusion, our findings indicate the importance of evaluating behaviours 
related to frontal lobe dysfunction during the agein  process in individuals with DS. 
Our initial hypothesis that executive dysfunction, disinhibition and apathy are present 
during the progression to dementia and that those behaviours are associated with the 
diagnosis, as well as with cognitive performance on tasks related to executive 
function, was confirmed by our analyses. There is a need for further studies including 
a longitudinal exploration of behaviours related to fr ntal lobe dysfunction in this 
population and involving structural and functional analysis of the brain, which could 
aggregate knowledge to identify the basis of the differential symptomatology of AD 
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(N = 92) (n = 62) (n = 17) (n = 13) 
Age (years), mean (SD) 42.43 (8.48) 39.69 (7.37)a 46.35 (5.06)b 50.46 (10.30)b 0.000c 
Male gender, n (%) 58 (63) 39 (62.9) 9 (63) 10 (76.9) 0.465d 
Degree of intellectual disability, n (%)         
Mild  34 (37) 28 (45.2)a 4 (23.5)a,b 2 (15.4)b   
Moderate  34 (37) 24 (38.7)a 9 (52.9)a 1 (7.7)b   
Severe  22 (23.9) 10 (16.1)a 4 (23.5)a 8 (61.5)b 
0.000e 
Unspecified 2 (2.2) 0
a 0a 2 (15.4)b 
Maternal age at delivery,f (years), mean (SD) 34.65 (7.69) 33.78 (7.37) 34.50 (9. 9) 39.25 (6.01) 0.087c 
Family history of AD, n (%) 23 (25) 12 (19)a 4 (23.5)a,b 7 (53.8)b 0.036e 
Use of medication affecting the CNS, n (%) 20 (21.7) 9 (14.5) a 3 (17.6) a 8 (61.5) b 0.002e 
Sedentary lifestyle, n (%) 36 (39.1) 19 (30.6)a 7 (41.2)a,b 10 (76.9)b 0.007e 
Living arrangements, n (%)          
0.002d 
Nursing home  3 (3.3) 0a 0a,b 3 (23.1)b 
Sheltered accommodation/assisted living  1 ( 1.1) 0a 0a 1 (7.7)a 
Home with relative  84 (91.3) 59 (95.2)a 17 (100)a 8 (61.5)b 
Own home/home with a partner  4 (4.3) 3 (4.8)a 0a 1 (7.7)a 
Relation to the informant, n (%)           
Parent 52 (56.5) 41 (66.1)a 8 (47.1)a,b 3 (23.1)b 
0.004d Sibling or other relative 38 (41.3) 21 (33.9)a 9 (52.9)a 8 (61.5)a 
Caregiver or other 2 (2.2) 0a 4 (16.7)a,b 2 (15.4)b 
Duration of contact (years), mean (SD) 41.92 (9.28) 39.74 (7.56)a 45.83 (5.51)b 47.23 (15.69)a,b 0.003c 
Education, n (%)      
0.457d 













Special school 39 (42.4) 27 (43.5) 6 (35.3) 6 (46.2) 
Special class in a mainstream school 4 (4.3) 3 (4.8) 1 (5.9) 0 
Mainstream school 24 (26.1) 19 (30.6) 2 (11.8) 3 (23.1) 
Employed,g n (%) 26 (28.6) 21 (34.4) 2 (11.8) 3 (23.1) 0.181d 
Key: AD, Alzheimer’s disease; CNS, central nervous sy tem. 
a,b Groups differ when p < 0.05. 
c Kruskal-Wallis test. 
d Fisher’s exact test. 
e Pearson’s chi-square test. 
f N=89 (no data for three individuals). 














Frontal Systems Behavior Scale scores and differencs among the diagnostic groups 








(N = 92) (n = 62) (n = 17) (n = 13) 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Apathy domain (14–70)      
All data 28.70 (14.13) 23.70 (9.42) 29.41 (11.37) 51.61 (13.88) 0.686 
Outliersb excluded  22.01 (6.98)   0.382 
Disinhibition domain (15–75)      
All data 24.40 (5.85) 22.51 (4.74)c 27.58 (4.96)d 29.23 (7.39)c,d 0.016 
Executive dysfunction domain (17–85)      
All data 43.75 (13.21) 38.80 (11.58)c 49.58 (9.87)d 59.69 (7.89)d 0.025 
Total (46–230)      
All data 96.85 (28.88) 85.03 (21.90) 106.58 (20.57)d 140.53 (19.93)d 0.059 
Outliersb excluded  82.27 (19.37)c   0.024 
Key: AD, Alzheimer’s disease; FrSBe, Frontal Systems Behavior Scale. 
a Linear regression, adjusted for age, genderm type of education, intellectual disability and use of medications affecting the central 
nervous system. 
b Values for four of the individuals in the stable cognition group were excluded. 















Correlation between the informant-reported Frontal Systems Behavior Scale score and performance on the 
cognitive tasks of the executive protocol devised by Ball et al. (2008) 
Executive protocol scores 
















Cognitive tasks     
Executive function     
Verbal Fluency −0.380a −0.191 −0.373a −0.381a 
Cats and Dogs −0.450a −0.395a −0.533a −0.539a 
Spatial Reversal −0.350a −0.282a −0.481a −0.446a 
Weigl Sorting −0.335a −0.377a −0.515a −0.499a 
Tower of London −0.436a −0.313a −0.530a −0.521a 
Scrambled Boxes −0.408a −0.327a −0.465a −0.482a 
Executive memory     
Prospective Memory −0.330a −0.407a −0.505a −0.474a 
Object Memory −0.488a −0.433a −0.540a −0.550a 
Total executive function −0.492a −0.429a −0.623a −0.612a 
CAMCOG-DS executive function 
and attention domain 
−0.430a −0.388a −0.497a −0.522a 
Key: FrSBe, Frontal Systems Behavior Scale; CAMCOG-DS, Cambridge Cognitive Examination for Older 
Adults with Down Syndrome. 















Cognitive performance on the cognitive tasks of the ex cutive protocol devised by Ball et al. (2008) and differences among 
the diagnostic groups 








(N=86*) (N=60) (N=16) (N=10) 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Cognitive tasks      
Executive function      
Verbal Fluency (0–5) 1.97 (0.99) 2.17 (0.92) 2.00 (.81) 0.70 (0.82) 0.515 
Cats and Dogs (0–16) 9.08 (6.21) 11.22 (5.27)b 6.06 (5.61)c 1.10 (3.47)c 0.012 
Spatial Reversal (0–7) 3.23 (2.82) 3.85 (2.69) 2.56 (2.78) 0.60 (1.89) 0.476 
Weigl sorting (0–5) 1.64 (1.89) 2.20 (1.94)b 0.56 (1.09)c 0.00 (0.00)b,c 0.015 
Tower of London (0–12) 4.49 (3.80) 5.68 (3.63)b 2.63 (2.94)c 0.30 (0.94)b,c 0.019 
Scrambled Boxes (0–11) 7.35 (3.16) 8.07 (2.91) 7.38 (1.99) 3.00 (2.86) 0.662 
Executive memory      
Prospective Memory (0–4) 2.12 (1.49) 2.68 (1.20)b 1.06 (1.52)c 0.40 (0.51)c 0.001 
Object Memory (0–10) 6.42 (3.28) 7.50 (2.57) 5.38 (.07) 1.60 (2.67) 0.252 
Total executive function 36.29 (18.64) 43.36 (15.47)b 27.62 (11.91)c 7.7 (10.05)d 0.013 
CAMCOG-DS executive function and 
attention domain 
9.93 (5.31) 11.15 (4.92) 10 (4.38) 2.5 (2.22) 0.584 
Key: AD, Alzheimer’s disease; CAMCOG-DS, Cambridge Cognitive Examination for Older Adults with Down Syndrome. 
* six individuals did not take part in the neuropsychological assessment 
a Linear regression, adjusted for age, gender, type of ducation, intellectual disability and use of medications affecting the 
central nervous system. 















Impact of the Frontal Systems Behavior Scale score on the odds of a clinical diagnosis, 
adjusted for age, gender, type of education, level of intellectual disability and use of 
medications affecting the central nervous system 
Comparison Odds ratio 95% CI p-value 
Prodromal dementia vs. stable cognition    
Disinhibition 1.222 1.060–1.408 0.006 
Executive dysfunction  1.091 1.022–1.164 0.009 
Total FrSBe 1.046 1.013–1.081 0.007 
AD vs. prodromal dementia    
Apathy  1.166 1.009–1.348 0.037 
AD vs. stable cognition    
Executive dysfunction  1.121 1.000–1.257 0.050 
Total FrSBe 1.120 1.024–1.225 0.013 

















• Disinhibition, executive dysfunction and apathy are predictive of a diagnosis 
of AD 
• Behaviours related to frontal lobe correlates with executive function 
performance 
• Behaviours related to frontal lobe dysfunction manifest during AD progression 
in DS 
• Frontal-subcortical behaviours should be taken into consideration during 
evaluation 
